Group 1 - The core point of the article is that CITIC Securities announced the issuance of a note under its offshore medium-term note program, with a total issuance amount of 6 million USD [1] - The note issuance is backed by CITIC Securities International, a wholly-owned subsidiary of CITIC Securities [1] - Following this issuance, the total principal balance of notes issued under the program amounts to 2.717 billion USD [1]

智通财经APP讯，中信证券(06030)发布公告，公司境外全资子公司中信证券国际有限公司(以下简称中 信证券国际)的附属公司CSI MTN Limited(以下简称发行人或被担保人)于2022年3月29日设立境外中期票 据计划(以下简称中票计划)，此中票计划由中信证券国际提供担保。根据存续票据到期情况，结合公司 业务发展实际需要，发行人于2025年11月6日在中票计划下发行一笔票据，发行金额600万美元。本次发 行后，发行人在中票计划下已发行票据的本金余额合计27.17亿美元。 ...

证券代码：600030 证券简称：中信证券 公告编号：临2025-081 累计担保情况 | 对外担保逾期的累计金额（万元） | - | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（亿元） | 1,836.43 | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 62.65 | | 特别风险提示 | □对外担保总额超过最近一期经审计净资产 | | | 100% | | | 担保金额超过上市公司最近一期经审计净 | | | 资产50% | | | □对合并报表外单位担保金额达到或超过最 | | | 近一期经审计净资产30%的情况下 | | | 对资产负债率超过70%的单位提供担保 | 1 中信证券股份有限公司 关于间接子公司发行中期票据 并由全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 | CSI | MTN | Limited | | --- | --- | --- | --- | - ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任 何責任。 （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） （股份代號：6030） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中信証券股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司關於間 接子公司發行中期票據並由全資子公司提供擔保的公告，僅供參閱。 承董事會命 证券代码：600030 证券简称：中信证券 公告编号：临2025-081 中信证券股份有限公司 关于间接子公司发行中期票据 并由全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 中信証券股份有限公司 董事長 張佑君 中國北京 2025年11月6日 於本公告刊發日期 ，本公司執行董事為張佑君先生及鄒迎光先生；本公司非執行董事為張麟先生 、付臨 ...

Core Points - The stock price of Yahui Pharmaceutical (688176.SH) closed at 9.81 yuan, reflecting a decline of 1.6% and indicating a state of breaking issue [1] - Yahui Pharmaceutical was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 7, 2022, with an issuance of 110 million shares at a price of 22.98 yuan per share [1] - The stock experienced a break on its first trading day, with an intraday high of 20.00 yuan, which remains the highest price since its listing [1] Fundraising and Financials - The total amount raised from the initial public offering (IPO) was 2.528 billion yuan, with a net amount of 2.381 billion yuan after deducting issuance costs [1] - The net amount raised exceeded the original plan by 311 million yuan, with the company initially aiming to raise 2.070 billion yuan [1] - The total issuance costs for the IPO amounted to 147 million yuan, with CITIC Securities receiving 130 million yuan as underwriting and sponsorship fees [1] Project Allocation - The funds raised are intended for various projects, including drug and medical device production, new drug research and development, marketing network construction, and supplementing working capital [1] Company Leadership - The controlling shareholder, actual controller, chairman, and general manager of Yahui Pharmaceutical is PAN KE, who holds American nationality [1]

新 1 社 主管主办 上海珍券系 (2)中国证券网 四分彩官 2025 11/6 市场回顾 沪指重返4000点 算力硬件股反弹带动创业 板指盘中涨超2% 日经225指数收涨1.34% 韩国综合指数收 涨0.55% 机 构 观点 瑞士宝盛:利好因素将支撑新兴市场股票继 续保持强劲势头 国信证券: 流动性收缩加速估值消化进程 短 期利空带来港股布局良机 中信证券:明年多种因素仍然可能驱动金价 上行 11月6日日间盘，国内商品期货主力合约多数收涨。截至15:00收盘，对二甲苯涨超3%，焦煤、PTA、烧碱等涨超2%，瓶片、橡胶、菜粕等涨超1%，纯 碱、沪金、锰硅等微涨。跌幅方面，集运指数（欧线）跌超3%，沥青跌超2%，丙烯跌超1%，玻璃、塑料、原油等微跌。 【机构观点】 瑞士宝盛股票策略研究部的Nenad Dinic近日发表观点指出，周期性和结构性利好因素将支撑新兴市场股票在2026年继续保持强劲势头。 兴业证券发布研报表示，基本面与流动性两大"支柱"出现动摇，导致了近期海外市场的动荡。具体来看，一是美联储官员近期释放鹰派言论，叠加美国政 府停摆引发的短期流动性紧张，导致市场对宽松周期的预期出现修正；二是市场对AI巨 ...

本文来自格隆汇专栏：中信证券研究 作者：姜娅 蒋祎 江旭东 张晟 当前啤酒行业正经历由价到质的转变，酒企面临消费者需求碎片化、渠道变革等新挑战，在精酿和门店 式鲜啤等啤酒新品类的冲击下龙头酒企份额有可能被持续侵蚀，中信证券认为率先对行业趋势进行正确 判断并做出及时应对的酒企有望巩固市场地位。此外，在明年成本大概率增加的背景下提价幅度和时点 的考虑也将影响到明年酒企的业绩表现，综合考虑上述因素以及消费弱复苏，判断2026年啤酒行业收入 和利润将持平微降，看好份额提升快、渠道管理强、产品势能好的企业。 ▍风险因素： 宏观消费需求不及预期；酒类生产成本上行压力加剧；竞争加剧；食品安全问题；宴请相关政策进一步 收紧。 ▍投资策略： 受到内需消费恢复缓慢、政商务相关宴请政策收紧的影响，2025年以来白酒板块股价表现疲软严重跑输 指数，年初至今（2025/10/31）中信白酒指数-4.6%，分别跑输沪深300/万得全A指数 22.5pcts /30.9pcts。 虽然短期内白酒行业基本面仍继续承压，但考虑到大部分上市酒企已开始逐步出清，中信证券判断2025 年下半年是本轮白酒行业的基本面底部，是动销最弱、批价最低、市场预 ...

来源：市场资讯 （来源：中信证券发布） 助力中国创新药走向世界 2025年11月6日，苏州旺山旺水生物医药股份有限公司（以下简称旺山旺水，2630.HK）成功于香港联 交所主板上市，发行规模约5.87亿港元。中信证券担任独家保荐人、整体协调人、联席全球协调人、联 席账簿管理人及联席牵头经办人。中信证券全球投资银行管理委员会联席主任程杰出席上市仪式。 2025年至今港交所22单医疗健康行业IPO，中信证券保荐10单 2025年至今港交所13单18A IPO，中信证券保荐7单 旺山旺水香港公开发行认购倍数6,238.42倍，在2025年香港联交所新上市的公司中排名医疗健康行业第 二、全市场第四 深耕神经精神、生殖健康与病毒感染领域 打造创新小分子药多元管线 旺山旺水致力于满足神经精神、生殖健康及病毒感染领域的临床需求，创始人团队来自中国科学院上海 药物研究所，系药物开发领域的著名科学家，拥有逾20年的行业经验。旺山旺水已形成极具竞争力且多 元化的创新药产品管线，其中两项处于商业化阶段，四项处于临床阶段，三项处于临床前阶段。本次上 市有助于提升旺山旺水的国际知名度以及影响力，进一步推进全球化研发，对旺山旺水的发展具 ...

Group 1 - The long-term price trend of gold is highly correlated with geopolitical and economic conditions, with upward drivers typically stemming from geopolitical turmoil and weak U.S. economic performance [1] - Current downward risks for gold prices include a recovering U.S. economy, hawkish Federal Reserve policies, strong fiscal discipline in the U.S., easing geopolitical tensions, and global central banks selling gold, none of which are currently significant [1] - In the long term, gold is expected to benefit from the expansion of global liquidity and increased preference due to risks associated with de-globalization [1] Group 2 - Listed securities firms and large brokerages reported a year-on-year net profit growth of 62% and 56% respectively for the first nine months of 2025 [2] - Key changes in the third quarter for large brokerages include continued total asset expansion, growth in financial investments and client funds, increased self-operated leverage, significant growth in brokerage services, and a recovery in investment banking [2] - The operating environment for brokerages is improving, with enhanced performance elasticity and sustainability, making the sector's valuation repair opportunities attractive [2] Group 3 - The demand for electrolytic aluminum grew by 3.9% from January to September, exceeding market expectations [3] - The market anticipates a 2.5% growth in domestic electrolytic aluminum consumption by 2025, driven by better-than-expected performance in new energy vehicles and photovoltaics [3] - The profitability of the electrolytic aluminum industry is expanding at high levels, improving the earnings and dividend capabilities of aluminum companies [3]

Core Viewpoint - Huaihe Energy plans to acquire 89.30% equity of Huaihe Energy Power Group from its controlling shareholder, Huainan Mining, through a combination of issuing shares and cash payment, pending approval from the China Securities Regulatory Commission [1][7]. Group 1: Transaction Details - The transaction involves a total price of 1,169,412.85 million yuan, with cash payment of 175,411.93 million yuan and share payment of 994,000.92 million yuan [5][6]. - The share issuance price is set at 3.03 yuan per share, which is not lower than 80% of the average trading price over the last 120 trading days prior to the pricing date [4][5]. - The number of shares to be issued for the acquisition is 3,280,531,105 shares [6]. Group 2: Valuation and Assessment - The total equity value of the target company, Huaihe Energy Power Group, is assessed at 1,309,532.87 million yuan using the asset-based approach, with a 22.23% increase from its book value [2][4]. - The final transaction price for the 89.30% equity is based on the approved valuation, amounting to 1,169,412.85 million yuan [4][5]. Group 3: Shareholding Structure Post-Transaction - After the transaction, the total share capital of Huaihe Energy will increase to 7,166,792,170 shares, with Huainan Mining and its concerted parties holding 80.08% of the shares [7]. - The public shareholding ratio will remain above 10%, ensuring compliance with stock listing requirements [7].